Advancements in Biotech and Healthcare Industries
Update: 2025-11-11
Description
March Biosciences receives FDA RMAT designation for their CD5-targeted CAR-T cell therapy, NanoViricides, Inc. announces a direct offering for working capital, Oncotelic Therapeutics and Sapu Bioscience highlight the potential of sub-15 nm nanoparticles in drug delivery, HeartBeam Inc. is recognized for innovation in portable ECG technology, and Senate Democrats agree to re-open the government without guarantee of healthcare insurance subsidies extension.
Comments
In Channel



